Showing results (31-40 of 79) with videos related to
Sort By:
Pageof 8
Kekkaku : [Tuberculosis]|June 7, 2016
[THE CURRENT SITUATION OF FOREIGN TUBERCULOSIS PATIENTS AND THEIR CONCURRENT HIV INFECTION IN HOKKAIDO]Kimiyuki Ikeda, Hirotaka Nishikiori, Shun Kondo, et al.BMC Pulmonary Medicine|May 9, 2020
Correction to: Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosisTakumi Yoshikawa, Mitsuo Otsuka, Hirofumi Chiba, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signalingNaoki Hyakushima, Hiroaki Mitsuzawa, Chiaki Nishitani, et al.The Journal of Biological Chemistry|July 9, 2009
Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2Koji Kuronuma, Hiroaki Mitsuzawa, Katsuyuki Takeda, et al.Respiratory Investigation|January 19, 2021
Characteristics of COVID-19 patients admitted into two hospitals in sapporo, Japan: Analyses and insights from two outbreak wavesTakeshi Hattori, Atsushi Saito, Hirofumi Chiba, et al.Respiratory Research|March 1, 2018
Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosisYouhei Takahashi, Atsushi Saito, Hirofumi Chiba, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|May 20, 2008
Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cellsKathryn Chmura, Xiyuan Bai, Mari Nakamura, et al.BMC Pulmonary Medicine|December 10, 2014
Distinct compartmentalization of SP-A and SP-D in the vasculature and lungs of patients with idiopathic pulmonary fibrosisHirotaka Nishikiori, Hirofumi Chiba, Shigeru Ariki, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 27, 2021
Early favipiravir treatment was associated with early defervescence in non-severe COVID-19 patientsSatoshi Fujii, Yuta Ibe, Tomoyuki Ishigo, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 26, 2022
Analysis of diagnostic performance and factors causing nonspecific reactions in SARS-CoV-2 rapid antigen detection testsNatsuki Narumi, Takashi Kondo, Yuki Sato, et al.Pageof 8